Large Cap Archives - Page 368 of 437

1 minute read

Goldman Sachs Bullish On M&A Deals Activity Picking Up In Late 2023

January 4, 8:30 AM

Goldman Sachs Group Inc (NYSE: GS) seems to be bullish on the recovery of global mergers & acquisition deals in the second half of 2023 despite slow economic growth and a weak credit market.

1 minute read

Why This Bank Analyst Is No Longer Bullish On Ally, Capital One

By Natan Ponieman

January 3, 3:44 PM

Banks are entering 2023 in a state of alert as national and global economies slide into a period of ever-increasing uncertainty.

ALLY

2 minute read

Southwest Airlines More Or Less Returns To Normal Schedule Amid Processing Refunds

By Vandana Singh

January 3, 9:00 AM

Southwest Airlines Co (NYSE: LUV) restored to more-normal operations this weekend after a cascade of flight cancellations over the holidays.

FDX

1 minute read

Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study

By Vandana Singh

January 3, 7:41 AM

Valneva SE (NASDAQ:VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The…

AZN

3 minute read

Is Tesla’s Q4 Delivery Miss Cause For Concern? ‘Bulls Will Not Be Super Happy’

By Natan Ponieman

January 2, 4:02 PM

Tesla (NASDAQ: TSLA) reported its year-end vehicle production and delivery numbers for 2022 on Monday, falling behind Wall Street estimates by about 3%.

TSLA

2 minute read

Barron’s Top Weekend Stock Picks: Tesla, Bed Bath & Beyond, Six Flags And Signs Bitcoin Whales Are Buying The Dip

By Michael Cohen

December 31, 4:48 PM

Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.

BBBY

2 minute read

Bulls And Bears Of The Week: Apple, AMC, Meta, And How Elon Musk Is Reacting To Tesla Stock Plunge

By Michael Cohen

December 31, 3:03 PM

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

AAPL

1 minute read

GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca

By Vandana Singh

December 30, 11:27 AM

GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth $1 billion-$2.5 billion and avoid getting into a 'bidding war.'

GSK

1 minute read

Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates

By Vandana Singh

December 30, 9:37 AM

Novavax Inc (NASDAQ:NVAX) has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates. The…

NVAX

4 minute read

FTX Exchange’s Assets Worth $3.5B Held By Bahamian Regulators, Italy PM To Meet Intel Over Chip Investment, New Oral COVID Antiviral Might Be Better Than Pfizer’s Paxlovid: Today’s Top Stories

By Vandana Singh

December 30, 8:50 AM

Reuters

$BNB